Vistagen TherapeuticsVTGN
NASDAQPharmaceuticals
$0.23-0.77%
No cached AI snapshot yet for VTGN.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
$23.99MMarket cap
$5.1452-week high
$0.4352-week low
770,494Avg volume (30d)
59 employees39.62M shares outstandinglisted 2009-07-01
Next earnings ~May 5, 2026
About Vistagen Therapeutics
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Latest News
Showing market-wide stock news
Euro: 1.150 target nears on Fed risk against US Dollar – ING
WTI falls near $100 as Saudi adds Oman route, US stocks surge
Yield on 10-year Treasury hovers above 5% as investors await Fed decision
Warsh’s Fed expected to hike rates 25bp as dot plot takes center stage
USD/JPY Price Forecast: Retreats from 155.50 with Fed’s policy in focus
Equities: Fed focus and energy shock – Deutsche Bank
Related Stocksin Pharmaceuticals
Ready to see the live AI view on VTGN?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing VTGN side-by-side with live signals.